lmnx-20201007

0001033905-20-000128.txt : 20201007 0001033905-20-000128.hdr.sgml : 20201007 20201006204313 ACCESSION NUMBER: 0001033905-20-000128 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20201007 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201007 DATE AS OF CHANGE: 20201006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LUMINEX CORP CENTRAL INDEX KEY: 0001033905 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 742747608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30109 FILM NUMBER: 201227926 BUSINESS ADDRESS: STREET 1: 12212 TECHNOLOGY BLVD STREET 2: 512-219-8020 CITY: AUSTIN STATE: TX ZIP: 78727 BUSINESS PHONE: 5122494741 MAIL ADDRESS: STREET 1: 12212 TECHNOLOGY BLVD CITY: AUSTIN STATE: TX ZIP: 78727 8-K 1 lmnx-20201007.htm 8-K lmnx-20201007

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 7, 2020 (October 7, 2020)

LUMINEX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

000-30109

74-2747608

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

12212 Technology Blvd.,

Austin,

Texas

78727

(Address of principal executive offices)

(Zip Code)

(512)

219-8020

Registrant’s Telephone Number, Including Area Code

None

(Former name or former address, if changed since last report.)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of exchange on which registered

Common Stock, $0.001 par value

LMNX

The Nasdaq Global Select Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Item 2.02. Results of Operations and Financial Condition.

On October 7, 2020, Luminex Corporation (the “Company”) issued a press release announcing, among other matters, its preliminary revenue for the third quarter ended September 30, 2020. A copy of the press release is furnished herewith as Exhibit 99.1.

The information in this Form 8-K and the Exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 7.01. Regulation FD Disclosure.

On October 7, 2020, the Company issued a press release announcing, among other matters, its preliminary revenue for the third quarter ended September 30, 2020. A copy of the press release is furnished herewith as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.


Exhibit No.						Description
99.1						Press Release issued by Luminex Corporation dated October 7 , 2020.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	LUMINEX CORPORATION

Date: October 7, 2020	By:	/s/ Harriss T. Currie
	Name:	Harriss T. Currie
	Title:	Chief Financial Officer, Senior Vice President of Finance
		(Principal Financial Officer)

EX-99 2 a2020-q3form8xkex99110.htm EX-99 Document

Exhibit 99.1

Luminex Corporation Pre-Release of 3^rd Quarter 2020 Revenue

Third Quarter Earnings Call Scheduled for November 2, 2020

AUSTIN, Texas (October 7, 2020) – Luminex Corporation (Nasdaq: LMNX) today announced 3^rd quarter 2020 revenues of approximately $106 million, up approximately 35% over the 3^rd quarter of 2019. Highlights include:

•Molecular Diagnostics revenue of approximately $60 million, up almost 100% vs. Q3 2019

•Licensed Technologies Group revenue of approximately $35 million, down 10% vs. Q3 2019

•Flow Cytometry revenue of approximately $10 million, up 13% vs. Q3 2019

“We successfully executed on our revised plan and finished the quarter with revenue of approximately $106 million from our strong and diversified business,” said Nachum “Homi” Shamir, Chairman, President, and CEO of Luminex. “We continue to experience tailwinds in our MDx business as we help combat the COVID-19 pandemic, with orders for our ARIES^®-based, COVID-19-related products continuing to outstrip our ability to supply. We have completed our planned expansion activities on our NxTAG^® line and the expansion of our ARIES^® manufacturing line should be completed during the 4^th quarter, and will help us to address the backlog and continued strong demand for our COVID-19-related PCR products. Our Clinical Tools and Life Science business is beginning to see recovery from pandemic lows, but we are still experiencing some headwinds. We are also looking forward to several near-term product launches that will further solidify our extensive portfolio.”

The full financial results for the quarter, and any changes to 2020 guidance and/or provision thereof, will be discussed on our third quarter earnings call, currently scheduled for November 2, 2020.

ABOUT LUMINEX CORPORATION

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at luminexcorp.com.

USE OF FORWARD-LOOKING STATEMENTS

Statements made in this release that express Luminex’s or management's intentions, plans, beliefs, expectations, or predictions of future events are forward-looking statements. Forward-looking statements in this release include statements regarding expected revenue and cost savings and projected 2020 performance, including revenue guidance. The words "expect," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements. Factors that could cause Luminex’s actual results or performance to differ materially include risks and uncertainties relating to, among others, negative effects from the worldwide COVID-19 pandemic (including but not limited to the general economic downturn related to such pandemic, travel restrictions related thereto, business closures that may affect our supply chain or our ability to install instruments, and delays in FDA clearances related to adjustments in the agency’s approval priorities in response to the pandemic), concentration of Luminex’s revenue in a limited number of direct customers and strategic partners, some of which may be experiencing decreased demand for their products utilizing or incorporating Luminex’s technology, budget or finance constraints in the current economic environment, or periodic variability in their purchasing patterns or practices as a result of internal resource planning challenges; market demand and acceptance of Luminex’s products and technology, including ARIES^®, MultiCode^®, xMAP^®, xMAP^® INTELLIFLEX, VERIGENE^®, VERIGENE^®II, Guava^®, Muse^®, Amnis^® and NxTAG^® products; Luminex’s ability to scale manufacturing operations and manage operating expenses, gross margins and inventory levels; Luminex’s ability to obtain and enforce intellectual property protections on Luminex’s products and technologies; the impact on Luminex’s growth and future results of operations with respect to the loss of the LabCorp women’s health business; Luminex’s ability to successfully launch new products in a timely manner; dependence on strategic partners for development, commercialization and distribution of products; risks and uncertainties associated with implementing Luminex’s acquisition strategy, Luminex’s challenge to identify acquisition targets, including Luminex’s ability to obtain financing on acceptable terms; Luminex’s ability to integrate acquired companies or selected assets into Luminex’s consolidated business operations, and the ability to fully realize the benefits of Luminex’s acquisitions; the timing of and process for regulatory approvals; competition and competitive technologies utilized by Luminex’s competitors; fluctuations in quarterly results due to a lengthy and unpredictable sales cycle; fluctuations in bulk purchases of consumables; fluctuations in product mix, and the seasonal nature of some of Luminex’s assay products; Luminex’s ability to comply with applicable laws, regulations, policies and procedures; the impact of the ongoing uncertainty in global finance markets and changes in governmental and governmental agency funding, including effects on the capital spending policies of Luminex’s partners and end users and their ability to finance purchases of Luminex’s products; changes in principal members of Luminex’s management staff; potential shortages, or increases in costs, of components or other disruptions to Luminex’s manufacturing operations; Luminex’s increasing dependency on information technology to improve the effectiveness of Luminex’s operations and to monitor financial accuracy and efficiency; the implementation, including any modification, of Luminex’s strategic operating plans; the uncertainty regarding the outcome or expense of any litigation brought against or initiated by Luminex; risks relating to Luminex’s foreign operations, including fluctuations in exchange rates, tariffs, customs and other barriers to importing/exporting materials and products in a cost effective and timely manner; difficulties in accounts receivable collections; Luminex’s ability to monitor and comply with foreign and international laws and treaties; and Luminex’s ability to comply with changes in international taxation policies; budget or finance constraints in the current economic environment, or periodic variability in their purchasing patterns or practices as a result of material resource planning challenges; reliance on third party distributors for distribution of specific Luminex-developed and manufactured assay products, as well as the risks discussed under the heading "Risk Factors" in Luminex’s Reports on Forms 10-K and 10-Q, as filed with the Securities and Exchange Commission. The forward-looking statements, including the financial guidance and 2020 outlook, contained herein represent the judgment of Luminex as of the date of this press release, and Luminex expressly disclaims any intent, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in Luminex’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


Contacts:

Investor Contact:
Harriss Currie
Sr. Vice President of Finance and CFO
hcurrie@luminexcorp.com
512-219-8020

Investor Relations Contact:
Carla Stanaford
cstanaford@luminexcorp.com
937-469-2120

Media Contact:
Michele Parisi
Bioscribe
mparisi@bioscribe.com
925-864-5028

EX-101.SCH 3 lmnx-20201007.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - COVER PAGE Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 lmnx-20201007_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 lmnx-20201007_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 lmnx-20201007_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Entity Tax Identification Number Entity Tax Identification Number Entity Central Index Key Entity Central Index Key Document Type Document Type Entity File Number Entity File Number Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Address, Postal Zip Code Entity Address, Postal Zip Code COVER PAGE [Abstract] COVER PAGE [Abstract] COVER PAGE [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 lmnx-20201007_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 lmnx-20201007_g1.jpg begin 644 lmnx-20201007_g1.jpg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end GRAPHIC 9 lum1n35smalla2211.jpg begin 644 lum1n35smalla2211.jpg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end XML 10 lmnx-20201007_htm.xml IDEA: XBRL DOCUMENT 0001033905 2020-10-07 2020-10-07 0001033905 false 8-K 2020-10-07 LUMINEX CORPORATION DE 000-30109 74-2747608 12212 Technology Blvd., Austin, TX 78727 (512) 219-8020 Common Stock, $0.001 par value LMNX NASDAQ false false false false false XML 11 R1.htm IDEA: XBRL DOCUMENT

COVER PAGE Document	Oct. 07, 2020
COVER PAGE [Abstract]
Written Communications	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common Stock, $0.001 par value
City Area Code	(512)
Entity Address, Address Line One	12212 Technology Blvd.,
Entity Incorporation, State or Country Code	DE
Entity File Number	000-30109
Document Type	8-K
Document Period End Date	Oct. 07, 2020
Entity Central Index Key	0001033905
Amendment Flag	false
Entity Registrant Name	LUMINEX CORPORATION
Entity Tax Identification Number	74-2747608
Entity Address, City or Town	Austin,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78727
Local Phone Number	219-8020
Trading Symbol	LMNX
Security Exchange Name	NASDAQ
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &6E1E$'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !EI4918YWNLNX K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$E&82;UI:.G#@8K;.QF;+4UBQUC:R1]^SE9FS*V!]C1TN]/ MGT"M#D+W$9]C'S"2Q70WNLXGH<.:G8B" $CZA$ZE,B=\;A[ZZ!3E9SQ"4/I# M'1%JSE?@D)11I& "%F$A,MD:+71$17V\X(U>\.$S=C/,:, .'7I*4)45,#E- M#.>Q:^$&F&"$T:7O IJ%.%?_Q,X=8)?DF.R2&H:A')HYEW>HX.UI]S*O6UB? M2'F-^5>R@LX!U^PZ^;79/.ZW3-:\YD7%"[[:UUS<-X(_O$^N/_QNPJXW]F#_ ML?%54+;PZR[D%U!+ P04 " !EI491F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M &6E1E%0($R0/@0 #P0 8 >&PO=V]R:W-H965T&UL MI9A=<^(V%(:OM[]"P_1B=X;$EB QV2',$$*VS"9 @?V8=GHA; &:V!(KBQ#^ M?8\,L6EKCFE[$R1;Y_6C(^F5E/96F^=T)80EKTFLTMO:RMKU1\]+PY5(>'JI MUT+!FX4V";=0-4LO71O!HRPHB3WF^]=>PJ6J==K9L['IM/7&QE*)L2'I)DFX MV=V)6&]O:[3V]F BEROK'GB=]IHOQ538+^NQ@9J7JT0R$2J56A$C%K>U+OUX MQYHN(&OQ58IM>E0FKBMSK9]=91#=UGQ')&(16B?!X>=%]$0<.R7@^'$0K>7? M=(''Y3?UAZSST)DY3T5/Q]]D9%>WM5:-1&+!-[&=Z.TOXM"A*Z<7ZCC-_I+M MOFVS62/A)K4Z.00#02+5_I>_'A)Q%-"@)P+8(8!EW/L/993WW/).V^@M,:XU MJ+E"UM4L&N"D2HBSG=[H:W]"QMU/?7*OPPWDV[8]"\+NM1<>1.[V M(NR$R"BTE\0/ZH3YS/]KN <\.13+H5BFUZB&^KT[3ZV!L?L#T6WDNHU,MWE" M]YN1U@I%>CI)-DJ&W$V,M*R_N,Z"QZE >)HY3Q/5Z2LK[8[T$V&64BW))XBW M*X>WYFI7QH7K57%=Y5Q7J,Y,VE@0O2"4O9]_(%,1;B!SI4"XD$LT++VIU>%S MG?SL7_H^)6MNR N/-QCI=4YZC7_ Y:\+=@1)BT09(![__HJR#PA'D',$YXQD M-XJ,2-/Z6X$\0CLR4J5DN")EC#(R$^%*Z5@O=^0N?HDNZPAK*V=MG<,Z4*$V M:VVR15"',>(6QMQ (C?*FMW)A.+B]WV$\"8GO#F'\$'"+!QNDKDP92"XAN_[ M%PV?^C<(#_4+E_3Q;AV\D_V?YM/!\>I;I3\12NIT-D(8\*1] 7.CQR]-@V/]. M>J/)>#3IS@:C(098F#_%3?L ...O9!!!RN3BL%,B:[%",FA>L* 97/LMC+ P M?8J[]M_=-ML%P+IF>JM*Z7"Y+ARSI,*LE1;[ /UW&T%NJV.C7Z0*RP<:UYQ] MQ] *VZ=G^7Z.-M:IA57ZFUR?]/H*Q: 5L !C*PR?XF[]J$- &:^TPAR_0H31 MFXM6Q0FT<'R&._;,\,B=R::[9*[C,IH*@<>G(39NK/!\AAOUV_&+]%_#%5=+ M<=(P*H2&W>E]]U>,Z>B CMOS5,SK6%RV967,'U7AC7 -XOM+9O%7?C MS/]AT/D34$L#!!0 ( &6E1E&#J:4#U $ #(& - >&PO+]*V-!^TQCG.+H MH6M9;QWPN@^#E&3IZ73/%!>:%ID>U(/"GE1FT)C3$V5%UAB],Z]I)'PI5T N M7.;T Y>B=&*NY4K(*=)I("HCC2/HK4!.D\#TSS&=1!1<+CI*:.,"R6*'^%LN MY3\E5M1[**3<#*8T$D5F.2(X_>#!7#R3+U)DB<^3]0Y;QZ"V-@E=J2*3T 0[3K1=^**Q+"01C?)!+7AK-)\]K".6P,M6(.53V,*OS97V MV)"X%Q_KL TD3'4-O:$EC#(1!/VC6M0^R-[]D2RQXF+P_>!GHV?\;3 (CPX: M,OZ[Z]R"!L?ET;0_^O_R*O^.8[;-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0 MT^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( &6E1E'G M,[FM/ $ # " / >&PO=V]R:V)O;VLN>&ULC5'1:L) $/R5A F!KXG&23&*KT:GY;-#:^?@> M$$/.2$[(EC@B7,/OO(71!0-F:)"_4]7=#:C(HD.+-RA2E:@H5'1](X\W (GC'_0Q]:DY\Z"QW#.MMK,9*J22*")?K W4:GK\7C!62Y1PW3 M*QH&O]0,:T]-C>[4RDB*^"Y&U\-P]B5._7]JI++$'):4-Q8<]SUZ,*U!%RJL M@XJ[E_4J&K;;=/+]\U!Z=SOCQ:?0LK33&+(3;NG?2Q1!X^*SY#U!+ P04 " !EI491 M)!Z;HJT #X 0 &@ 'AL+U]R96QS+W=O M[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9 MBBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%02P,$% @ M9:5&4660>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P M$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>L MWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH M>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G M(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6 M&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O M>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+ MX3]>?P%02P$"% ,4 " !EI491!T%-8H$ "Q $ M@ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( &6E1E%CG>ZR[@ M "L" 1 " :\ !D;V-0&UL4$L! A0#% @ 9:5&45 @3) ^! /! !@ M ("!#0@ 'AL+W=O7!E&UL4$L%!@ 0 ) D /@( $3 $! end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - COVER PAGE Document Sheet http://www.luminexcorp.com/role/COVERPAGEDocument COVER PAGE Document Cover 1 false false All Reports Book All Reports lmnx-20201007.htm a2020-q3form8xkex99110.htm lmnx-20201007.xsd lmnx-20201007_cal.xml lmnx-20201007_def.xml lmnx-20201007_lab.xml lmnx-20201007_pre.xml lmnx-20201007_g1.jpg http://xbrl.sec.gov/dei/2019-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "lmnx-20201007.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "lmnx-20201007_cal.xml" ] }, "definitionLink": { "local": [ "lmnx-20201007_def.xml" ] }, "inline": { "local": [ "lmnx-20201007.htm" ] }, "labelLink": { "local": [ "lmnx-20201007_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "lmnx-20201007_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "lmnx-20201007.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lmnx", "nsuri": "http://www.luminexcorp.com/20201007", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lmnx-20201007.htm", "contextRef": "ie7a7684dfe444bd3a6dd5a33173cc1f0_D20201007-20201007", "decimals": null, "first": true, "lang": "en-US", "name": "dei:WrittenCommunications", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - COVER PAGE Document", "role": "http://www.luminexcorp.com/role/COVERPAGEDocument", "shortName": "COVER PAGE Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lmnx-20201007.htm", "contextRef": "ie7a7684dfe444bd3a6dd5a33173cc1f0_D20201007-20201007", "decimals": null, "first": true, "lang": "en-US", "name": "dei:WrittenCommunications", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.luminexcorp.com/role/COVERPAGEDocument" ], "xbrltype": "booleanItemType" }, "lmnx_COVERPAGEAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "COVER PAGE [Abstract]", "label": "COVER PAGE [Abstract]", "terseLabel": "COVER PAGE [Abstract]" } } }, "localname": "COVERPAGEAbstract", "nsuri": "http://www.luminexcorp.com/20201007", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0001033905-20-000128-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001033905-20-000128-xbrl.zip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end